Wednesday, February 10, 2010, 12:03PM AEST - The Australian Stockmarket closes in 4 hours and 2 minutes.
To create a watchlist or portfolio of shares, Register

Novartis AG (NVS)

8:01AM AEST: 53.58 USD  Up 0.50 (0.94%)  
 MORE ON NVS 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 NOVARTIS AG ADS (NYSE:NVS) Delayed quote dataEdit
Last Trade:53.58 USD
Trade Time: 8:01AM AEST
Change:Up 0.50 (0.94%)
Prev Close:53.08
Open:53.23
Bid:N/A
Ask:N/A
1y Target Est:57.59
Day's Range:53.06 - 53.79
52wk Range:33.34 - 56.42
Volume:2,507,700
Avg Vol (3m):2,198,430
Market Cap:121.69B
P/E (ttm):16.04
EPS (ttm):3.34
Div & Yield:1.72 (3.24%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add NVS to Portfolio   Download Data

 HEADLINES 
BBH Core Select's Weightings Shift
Investor's Business Daily (Wed 9:30AM)
How Much Should Cancer Drugs Cost?
at The Wall Street Journal Online (Wed 8:05AM)
Bone Up On This Potential Blockbuster
at Motley Fool (Wed 3:58AM)
Europe Launches Probe into Pharma Deals
at BusinessWeek (Wed 2:52AM)
Germany Cancels Swine Flu Vaccines
at BusinessWeek (Wed 2:52AM)
Positive Results on Amgen Drug
Zacks.com (Wed 2:49AM)
5-Star Stocks Poised to Pop: ISTA Pharmaceuticals
at Motley Fool (Wed 1:44AM)
Indications: U.S. futures recover after sub-10,000 Dow close
at MarketWatch (Wed 12:59AM)
InPlay: Novartis gains exclusive rights to Debio 025, an antiviral agent in Phase IIb development as potential first-in-class Hepatitis C Therapy
Briefing.com (Tue 11:32PM)
Novartis licenses Hepatitis C drug
at MarketWatch (Tue 5:26PM)
UPDATE - Cell Therapeutics drug draws US FDA staff concerns
at Reuters (Tue 11:43AM)
3 Stocks I Saw on TV
TheStreet.com TV (Tue 12:40AM)
More Headlines for NVS...

 ANALYST 
EPS Est (next year) (Dec-09) :3.98
EPS Est (in 2 years) (Dec-10) :4.46
Avg Rec (current)*:2.2
PEG Ratio:2.71
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. Its Pharmaceuticals division engages in the research, development, manufacture, distribution, and sale of pha...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices